Figure 3
Figure 3. PolyP drives thrombin generation in histone-treated PRP. (A) Recalcified CTI-inhibited PRP was incubated with histones (40 μg/mL) in the presence of Psp (10 U/mL), and then thrombin generation was evaluated. Representative tracings of 3 experiments with PRP from different donors are shown. Recalcified CTI-inhibited PPP (B) and PPP treated with an anti-FXII antibody (150 μg/mL; C) were incubated with histones (40 μg/mL) and/or polyP (20 μg/mL), as described in “Methods,” and then thrombin generation was evaluated in the presence of liposomes. One representative experiment of 3 is shown.

PolyP drives thrombin generation in histone-treated PRP. (A) Recalcified CTI-inhibited PRP was incubated with histones (40 μg/mL) in the presence of Psp (10 U/mL), and then thrombin generation was evaluated. Representative tracings of 3 experiments with PRP from different donors are shown. Recalcified CTI-inhibited PPP (B) and PPP treated with an anti-FXII antibody (150 μg/mL; C) were incubated with histones (40 μg/mL) and/or polyP (20 μg/mL), as described in “Methods,” and then thrombin generation was evaluated in the presence of liposomes. One representative experiment of 3 is shown.

Close Modal

or Create an Account

Close Modal
Close Modal